We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Skip to main content
Log in

99mTc-nebivolol as a novel heart imaging radiopharmaceutical for myocardial infarction assessment

  • Published:
Journal of Radioanalytical and Nuclear Chemistry Aims and scope Submit manuscript

Abstract

Non-invasive quantification of myocardial β-receptors could become an independent prognostic marker for chronic heart failure and cardiovascular disorders. The aim of this study was to formulate a novel radiopharmaceutical for the detection of myocardial infarction at early stages in susceptible patients, which requires the development of high myocardium affinity radiopharmaceuticals able to establish an accurate in vivo quantification of cardiac β1-adrenoceptors. This was attained by the direct complexation of nebivolol as a cardioselective agent with technetium-99m as one of the most useful radionuclides in diagnostic nuclear medicine. Factors affecting the radiochemical yield such as nebivolol amount, stannous chloride amount, reaction time and pH of the reaction mixture were optimized. The results showed that the radiochemical yield was 95 ± 2.87 % and the radiolabeled compound was separated by high performance liquid chromatography. In vitro studies showed that the formed complex was stable for up to 24 h. In vivo uptake of 99mTc-nebivolol in the heart was 4.55 ± 0.23 % ID/g organ at 0.5 h post injection, whereas the clearance from Albino mice appeared to proceed via the hepatobiliary and renal clearance pathways. Predosing mice with cold nebivolol reduced the heart uptake to 1.1 ± 0.02 % and further confirmed the high specificity and selectivity of this radiotracer for the assessment of the myocardial β1-adrenoceptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Indian Pharmacopoeia (2010) vol 3. New Delhi, p 1753

  2. Pawels PJ, Gommery W, Van Lommen G, Janssen PAJ, Leysen JE (1989) Mol Pharmacol 34:843

    Google Scholar 

  3. Pawels PJ, Gommery W, Van Gompel P, Leysen JE (1991) Biochem Pharmacol 42:1683

    Article  Google Scholar 

  4. The NIH Website. http://dailymed.nlm.nih.gov/dailymed/. Accessed 10 2008

  5. Bundkirchena A, Nguyena Q, Brixiusa K, Bölck B, Mehlhorn U, Schwingera RHG (2003) Eur J Pharmacol 476:97

    Article  Google Scholar 

  6. Brixiusa K, Bundkirchena A, Bölck B, Mehlhorn U, Schwinger RHG (2001) Br J Pharmacol 133:1330

    Article  Google Scholar 

  7. Maack C, Tyroller S, Schnabel P, Cremers B, Dabew E, SuÈdkamp M, BoÈhm M (2001) Br J Pharmacol 132:1817

    Article  CAS  Google Scholar 

  8. Mangrella M, Rossi F, Fici F (1998) Pharmacol Res 38:419

    Article  CAS  Google Scholar 

  9. Münzel T, Gori T (2009) J Am Coll Cardiol 54:16

    Article  Google Scholar 

  10. Schnabel P, Maack C, Mies F, Tyroller S, Scheer A, Böhm M (2000) J Cardiovasc Pharmacol 36:466

    Article  CAS  Google Scholar 

  11. Smith C, Teitler M (1999) Cardiovasc Drugs Ther 13:123

    Article  CAS  Google Scholar 

  12. Cheng YC, Prussoff WH (1973) Biochem Pharmacol 22:3099

    Article  CAS  Google Scholar 

  13. Sarsero D, Molenaar P, Kaumann AJ, Freestone NS (1999) Br J Pharmacol 128:1445

    Article  CAS  Google Scholar 

  14. Brodde OE, Michel MC (1999) Pharmacol Rev 51:651

    CAS  Google Scholar 

  15. Molenaar P, Parsonage WA (2005) Trends Pharmacol Sci 26:368

    Article  CAS  Google Scholar 

  16. Brodde OE, Bruck H, Leineweber K (2006) J Pharmacol Sci 100:323

    Article  CAS  Google Scholar 

  17. Castellano M, Böhm M (1997) Hypertension 29:715

    Article  CAS  Google Scholar 

  18. Yamada S, Ohkura T, Uchida S, Inabe K, Iwatani Y, Kimura R, Hoshino T, Kaburagi T (1996) Life Sci 58:1737

    Article  CAS  Google Scholar 

  19. Khamssi M, Brodde OEJ (1996) Cardiovasc Pharmacol 16(Suppl 5):S133

    Google Scholar 

  20. Brodde OE, Zerkowski HR, Doetsch N, Motomura S, Khamssi M, Michel MC (1989) J Am Coll Cardiol 14:323

    Article  CAS  Google Scholar 

  21. Anthonio RL, Brodde OE, van Veldhuisen DJ, Scholtens E, Crijns HJ, van Gilst WH (2000) Int J Cardiol 72:137

    Article  CAS  Google Scholar 

  22. Schäfers M, Dutka D, Rhodes CG, Lammertsma AA, Hermansen F, Schober O, Camici PG (1998) Circ Res 82:57

    Article  Google Scholar 

  23. Dubois EA, van den Bos JC, Doornbos T, van Doremalen PA, Somsen GA, Vekemans JA, Janssen AG, Batink HD, Boer GJ, Pfaffendorf M, van Royen EA, van Zwieten PA (1996) J Med Chem 39:3256

    Article  CAS  Google Scholar 

  24. van den Bos C, van Doremalen PA, Dubois E, Somsen GA, Vekemans JA, Janssen AG, Boer GJ, Pfaffendorf M, van Royen EA, van Zwieten PA (1997) Nucl Med Biol 24:1

    Article  Google Scholar 

  25. Dubois EA, Somsen GA, van den Bos JC, Janssen AG, Batink HD, Boer GJ, van Royen EA, van Zwieten PA (1997) Nucl Med Biol 24:9

    Article  CAS  Google Scholar 

  26. Elsigna PH, van Waarde A, Jaeggi KA, Schreiber G, Heldoorn M, Vaalburg W (1997) J Med Chem 40:3829

    Article  Google Scholar 

  27. de Jong RM, Willemsen ATM, Slart RHJA, Blanksma PK, van Waarde A (2005) Eur J Cardiovasc Nurs 4:99

    Article  Google Scholar 

  28. Delforge J, Syrota A, Lancon JP, Nakajima K, Loch C, Janier M, Vallois JM, Cayla J, Crouzel C (1991) J Nucl Med 32:739

    CAS  Google Scholar 

  29. Soloviev DV, Matarrese M, Moresco RM, Todde S, Buonasera TA, Sudati F, Simonelli P, Magni F, Colombo D, Carpinelli A, Kienle MG, Fazio F (2001) Neurochem Int 38:169

    Article  CAS  Google Scholar 

  30. Valette H, Dolle F, Guenther I, Demphel S, Rasetti C, Hinnen F, Fuseau C, Crouzel C (1999) Nucl Med Biol 26:105

    Article  CAS  Google Scholar 

  31. van Waarde A, Meeder JG, Blanksma PK, Brodde OE, Visser GM, Elsinga PH, Paans AMJ, Vaalburg W, Lie KI (1992) Eur J Pharmacol 1:107

    Article  Google Scholar 

  32. Elsigna PH, van Waarde A, Visser GM, Vaalburg W (1994) Nucl Med Biol 21:207

    Google Scholar 

  33. Motaleb MA, Moustapha ME, Ibrahim IT (2011) JRNC 289:239–245

    CAS  Google Scholar 

  34. Law MP, Wagner S, Kopka K, Rennera C, Pike VW, Schober O, Schäfers M (2010) Nucl Med Biol 37:517

    Article  CAS  Google Scholar 

  35. Pike VW, Law MP, Osman S, Davenport RJ, Rimordi O, Giardina D, Camici PG (2000) Pharm Acta Helv 74:191

    Article  CAS  Google Scholar 

  36. Kopka K, Law MP, Breyholz HJ, Faust A, Höltke C, Riemann B, Schober O (2005) Curr Med Chem 12:2057

    Article  CAS  Google Scholar 

  37. Gupta Y, Shrivastava A, Duggal D, Patel A, Agrawal S (2009) J Young Pharmacists 1:264

    Article  CAS  Google Scholar 

  38. Moustapha ME, Motaleb MA, Ibrahim IT (2011) JRNC 287:1

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. E. Moustapha.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sakr, T.M., Moustapha, M.E. & Motaleb, M.A. 99mTc-nebivolol as a novel heart imaging radiopharmaceutical for myocardial infarction assessment. J Radioanal Nucl Chem 295, 1511–1516 (2013). https://doi.org/10.1007/s10967-012-2168-1

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10967-012-2168-1

Keywords

Navigation